Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, September 2003, p. 2922-2928, Vol. 47, No. 9
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.9.2922-2928.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
New Klebsiella oxytoca ß-Lactamase Genes blaOXY-3 and blaOXY-4 and a Third Genetic Group of K. oxytoca Based on blaOXY-3
Sophie A. Granier,1,3 Véronique Leflon-Guibout,2 Fred W. Goldstein,1 and Marie-Hélène Nicolas-Chanoine2,3*
Service de Microbiologie-Hygiène, Hôpital Ambroise Paré, Boulogne-Billancourt,2
UFR Médicale Paris-Ile-de-France-Ouest, Université de Versailles-Saint-Quentin-en-Yvelines, Versailles,3
Laboratoire de Microbiologie Médicale, Fondation Hôpital Saint-Joseph, Paris, France1
Received 3 March 2003/
Returned for modification 29 April 2003/
Accepted 10 June 2003

ABSTRACT
The two genetic groups (oxy-1 and oxy-2) previously identified
in the
Klebsiella oxytoca taxon are recognizable by four independent
molecular markers: (i) ERIC-1R profiles, (ii) 16S ribosomal
DNA (rDNA) signature sequences, (iii) singular nucleotides in
a defined fragment of the
rpoB gene, and (iv) the type of the
strain's
blaOXY gene (i.e.,
blaOXY-1 or
blaOXY-2).
K. oxytoca strains SG266 and SG271 could not be classified into these genetic
groups based on their ERIC-1R profile and
blaOXY gene sequence.
With regard to the gene identity percentages between the
blaOXY-1 and
blaOXY-2 gene groups (86.8% ± 0.4%) and within a
blaOXY gene group (>99%), it was concluded that the
blaOXY gene of strain SG271 was representative of a new
blaOXY gene
group (
blaOXY-3), since the mean identity percentages between
it and the two
blaOXY gene groups were 85.5% ± 0.2% and
84.4% ± 0.4%, respectively. Since the corresponding percentages
were 95.0% ± 0.4% and 86.2% ± 0.3% for strain
SG266, it was impossible to classify its
blaOXY gene, which
was therefore named
blaOXY-4. The 16S rDNA signature sequences
of the two strains could be determined only after cloning experiments.
The SG266 clones displayed the same signature sequence as that
of the genetic group oxy-1, whereas the SG271 clones displayed
three different 16S rDNA signature sequences that also differed
from those of the two genetic groups. Singular nucleotides were
found within the
rpoB sequence of the two strains, allowing
for their distinction from the two genetic groups. All of these
results, combined with those previously obtained by the ERIC-1R
PCR method, indicate that strain SG271 is representative of
a new
K. oxytoca genetic group (oxy-3), whereas strain SG266
could not be classified.

INTRODUCTION
In 1974, Jain et al. (
15) were able to distinguish the
Oxytocum group from the
Klebsiella genus by DNA-DNA hybrization. In spite
of this discovery and also the fact that
K. oxytoca strain 497-2
(ATCC 13182
T) included in their analysis was a typical representative
of this new taxon, these authors did not suggest a new genus
of
Enterobacteriaceae, concluding that such a suggestion might
contribute to further confusion for bacteriologists, since
Oxytocum organisms look like true
Klebsiella with the exception of an
indole reaction. This absence of a specific name is undeniably
linked to the fact that true
Klebsiella oxytoca strains had
received multiple names (
Klebsiella aerogenes and
Klebsiella pneumoniae) until 1986, when
Klesiella nomenclature was changed
(
2,
12). Although less common than
K. pneumoniae in human infectious
diseases (
23),
K. oxytoca was the object of particular interest
since some strains were found as early as 1980 with a singular
ß-lactam resistance phenotype in comparison with
K. pneumoniae strains. In fact, these
K. oxytoca strains were found
to be resistant to aztreonam in the first assays performed with
this molecule by the manufacturer (
24). Fifteen years later,
Fournier et al. (
9) demonstrated that this aztreonam resistance
was due to mutations located in the promoter region of the gene
(
blaOXY) encoding the class A chromosomal ß-lactamase
(KOXY) of the resistant strains. Fournier et al. (
11) also showed
that the
blaOXY genes were made up of two groups (
blaOXY-1 and
blaOXY-2) on the basis of the gene nucleotide sequence, with
an identity percentage between the two gene groups of 87%. The
corresponding KOXY ß-lactamases were subsequently
classified into the ß-lactamase groups OXY-1 and OXY-2.
More recently, an
Enterobacteriaceae taxonomic analysis based
on the sequence of certain fragments of the 16S ribosomal DNA
(rDNA) and
rpoB genes showed that
K. oxytoca constitutes a monophylogenetic
species clearly separated from
K. pneumoniae (
7). However, through
different molecular studies, Brisse et al. (
3) and Granier et
al. (
14) have shown that the
K. oxytoca taxon is divided into
two clades. We also determined that each clade corresponds to
a
K. oxytoca genetic group (oxy-1 or oxy-2) recognizable by
four independent molecular markers: (i) characteristic bands
in the profiles generated by the ERIC-1R PCR method, (ii) a
signature sequence in a 16S rDNA fragment located from position
435 to position 458 according to the numbering of the
Escherichia coli 16S rDNA sequence, (iii) singular nucleotides dispersed
over the entire length of the 512-bp fragment of the
rpoB gene
shown by Mollet et al. (
18) to identify enterobacterial species,
and (iv) the type of the strain's
blaOXY (
blaOXY-1 or
blaOXY-2)
gene (
14).
Using the ERIC-1R PCR method to classify a panel of K. oxytoca clinical isolates into these two genetic groups, we detected two particular K. oxytoca strains: SG266 and SG271. In fact, neither their ERIC-1R profiles nor the sequences of their blaOXY genes allowed us to classify them into the two K. oxytoca genetic groups previously described (13). Thus, the present study was carried out to determine whether these two isolates might be representative of two new K. oxytoca genetic groups.

MATERIALS AND METHODS
Bacterial strains and plasmids.
Strains SG266 and SG271, identified by the routine method (API
System; bioMérieux, Marcy l'Étoile, France) as
K. oxytoca were obtained, both in 2000, from two patients hospitalized
in the Saint Joseph Hospital in Paris (
13). Strain SG266 infected
a diabetic foot wound, and strain SG271 was isolated from peritoneal
fluid.
E. coli strain Epicurian Coli XL10-Gold and plasmid pPCR-Script
(Cam
R; Stratagene, La Jolla, Calif.) were used for cloning experiments.
K. oxytoca strains ATCC 13182T and SC 10,436, which both harbored a blaOXY-2 gene controlled by a low and a strong promoter, respectively (12, 14), were used as control strains in ß-lactam MIC tests.
Biochemical identification.
Strains SG266 and SG271 were resubmitted to biochemical identification by using the BIOTYPE-100 carbon source strip system (bioMérieux). This test was performed by the French Enterobacteriaceae Reference Center (Institut Pasteur, Paris, France).
ß-Lactam susceptibility.
ß-Lactam susceptibility was determined by the agar dilution method on Mueller-Hinton agar with a Steers multiple inoculator and 104 CFU per spot. The following antibiotics were tested: amoxicillin (GlaxoSmithKline, Marly-le-Roi, France); ticarcillin (GlaxoSmithKline), alone or combined with 2 µg of clavulanate (GlaxoSmithKline)/ml; piperacillin (Wyeth-Lederle, Paris-La Defense, France), alone or combined with 4 µg of tazobactam (Wyeth-Lederle)/ml; cephalothin (Lilly, Suresnes, France); cefotaxime (Aventis, Paris, France); ceftazidime (GlaxoSmithKline); cefepime (Bristol-Myers Squibb, Paris-La Defense, France); aztreoman (Sanofi Winthrop, Gentilly, France); cefoxitine (Panpharma, Fougeres, France); and imipenem (Merck Sharp & Dohme-Chibret, Paris, France). The results were interpreted according to the French Antibiogram Committee recommendations (1).
blaOXY gene and KOXY ß-lactamase sequence comparison.
The blaOXY genes of strains SG266 and SG271 (GenBank accession numbers AY077481 and AF491278, respectively) and the corresponding KOXY ß-lactamases were aligned by using Align software (20), with the blaOXY genes and the corresponding proteins registered under the following GenBank accession numbers: Z30177, Y17715, AY077486, AY077484, AY077483, AY077482, and M27459 for the blaOXY-1 genes and Z49084, AF473577, AY055205, AY077489, AY077488, AY077487, AY077485, D84548, and Y17714 for the blaOXY-2 genes. Three blaOXY-1 genes (strains 756, 563, and 1879-77) and three blaOXY-2 genes (strains K1794, 11V, and KER) that had been published (10, 22) but not submitted to GenBank were also included in the comparative analysis.
Preparation of crude extracts and isoelectrofocusing.
This experiment was performed as previously described (17).
The pI values of the ß-lactamases produced by strains SG266 and SG271 were determined by comparison with the pI values of known ß-lactamasesOXY-2-1 (pI 5.2), TEM-1 (pI 5.4), TEM-2 (pI 5.6), PSE-2 (pI 5.7), SHV-3 (pI 7), OXY-1-1 (pI 7.5), ACC-1 (pI 7.75), and SHV-5 (pI 8.2)and isoelectrofocusing standards (Bio-Rad Laboratories, Hercules, Calif.).
KOXY ß-lactamase phylogenetic tree.
The amino acid sequences of the KOXY ß-lactamases previously published (2, 9-12, 14, 16, 22, 25) and those of the ß-lactamases of strains SG266 and SG271 were aligned by using Dialign 2 software (19). The KOXY ß-lactamase phylogenetic tree was built with TreeTop software from GeneBee services (4).
PCR, sequencing, and comparison of rpoB and 16S rDNA genes.
The 512-bp fragment of the rpoB gene and the 387-bp fragment of the 16S rDNA gene, allowing for the identification of enterobacterial species (7) and K. oxytoca genetic groups, were amplified from strains SG266 and SG271 and sequenced as previously described (14). The rpoB sequences were then directly compared by using Align software (20) to the previously published rpoB consensus sequences characteristic of the K. oxytoca genetic groups oxy-1 and oxy-2 (14). For the 16S rDNA fragment, the sequences were compared to the 16S rDNA consensus sequences only after cloning experiments.
16S rDNA cloning experiments and analysis of recombinant plasmids.
The 16S rDNA amplified product obtained from strains SG266 and SG271was purified and then cloned into pPCR-Script cloning vector according to the manufacturer's recommendations (Stratagene, La Jolla, Calif.). The recombinant plasmids were transferred into E. coli XL10-Gold by using the heat shock method. Transformants were selected onto agar plates containing chloramphenicol (30 mg/liter), X-Gal (5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside; 40 mg/liter), and IPTG (isopropyl-ß-D-thiogalactopyranoside; 40 mg/liter), and those displaying a white color were analyzed. Thus, the fragment inserted into the recombinant plasmids was amplified by using the plasmidic T3 and T7 primers; fragments with the expected size were then sequenced.
GenBank accession numbers.
The rpoB gene partial sequences of strains SG266 and SG271 have been registered in GenBank database under accession numbers AF491282 and AF491280, respectively.

RESULTS
blaOXY gene and KOXY ß-lactamase comparison.
As indicated in Table
1, pairwise comparative analysis of the
blaOXY gene of strains SG266 and SG271 and the
blaOXY genes
previously published, i.e., 10
blaOXY-1 and 12
blaOXY-2 genes
showed that the mean percentages of
blaOXY gene identity were
95.0% ± 0.4% and 86.2% ± 0.3% for strain SG266
and
blaOXY-1 and
blaOXY-2 genes, respectively, and 85.5% ±
0.2% and 84.4% ± 0.4%, respectively, for strain SG271.
These percentages were 86.8% ± 0.4% between the
blaOXY-1 and the
blaOXY-2 genes and only 85.8% between the
blaOXY genes
of strains SG266 and SG271. The comparison of the KOXY ß-lactamases
encoded by all of these
blaOXY genes allowed us to determine
that certain amino acids (
n = 34) located at positions not previously
defined as being involved in the enzymatic active site (
8) were
singular for one of the four ß-lactamase types: OXY-1
group, OXY-2 group, the KOXY ß-lactamase of strain
SG266, and the KOXY ß-lactamase of strain SG271 (Table
2) A particular amino acid was more often observed in the KOXY
ß-lactamase of strain SG271 (
n = 15) and the OXY-2
group (
n = 14) than in the OXY-1 group (
n = 3 or 5) or the KOXY
ß-lactamase of strain SG266 (
n = 3). As indicated
in Table
2, the pI values of the ß-lactamases of strains
SG266 and SG271 were 7.7 and 6.7, respectively.
View this table:
[in this window]
[in a new window]
|
TABLE 1. Identity percentages between the nucleotide sequences of the blaOXY and rpoB genes of K. oxytoca strains SG266 and SG271 and the previously published blaOXY genes and the rpoB consensus sequences characteristic of the K. oxytoca genetic groups oxy-1 and oxy-2
|
View this table:
[in this window]
[in a new window]
|
TABLE 2. pI values and discriminant amino acids for OXY-1 and OXY-2 ß-lactamase groups and the ß-lactamases of K. oxytoca strains SG266 and SG271
|
According to the phylogenetic tree constructed from the amino
acid sequence of all of these KOXY ß-lactamases, we
observed three phylogenetically distant branches (Fig.
1). The
first branch included all of the OXY-1 ß-lactamases
tested and the KOXY ß-lactamase of strain SG266 which
was, however, the most distant ß-lactamase in this
ß-lactamase group. The second branch included only
the KOXY ß-lactamase of strain SG271, and the third
branch included exclusively the OXY-2 ß-lactamases
tested. This subdivision was obtained with bootstrap values
of 100%.
ß-Lactam MICs.
As indicated in Table
3 K. oxytoca strains SG266 and SG271 were
resistant to amoxicillin and ticarcillin but susceptible to
these two molecules when they were combined with 2 µg
of clavulanate/ml and were also susceptible also to all other
ß-lactam molecules tested.
rpoB and 16S rDNA sequence comparison.
The comparison (Table
1) of the 512-bp fragment of the
rpoB gene of strains SG266 and SG271 with the two
rpoB consensus
sequences previously defined for the strains belonging to the
K. oxytoca genetic groups oxy-1 and oxy-2, respectively, showed
that the percentage of identity was higher between strain SG266
and the oxy-1 genetic group (96.5%) than between strain SG266
and the oxy-2 genetic group (95.3%) and, inversely, higher between
strain SG271 and the oxy-2 genetic group (97.3%) than between
strain SG271 and the oxy-1 genetic group (96.5%). The percentage
of the
rpoB gene identity between strains SG266 and SG271 was
only 95.9%, whereas this percentage was 96.7% between the two
rpoB consensus sequences (Table
1). The nucleotide differences
observed all along the 512-bp
rpoB fragment between strain SG266,
strain SG271, the consensus sequence of the genetic group oxy-1,
and that of the genetic group oxy-2 resulted in several singular
nucleotides at given positions according to the two genetic
groups and the two strains (Table
4) Thus, C162, T258, C264,
C270, C276, and G285 were only observed in the
rpoB consensus
sequence of the genetic group oxy-1, whereas A3, C114, C123,
and T339 were only observed in that of the genetic group oxy-2.
Six (T2, T3, A36, G84, A108, and G141) and nine (C87, T108,
T168, C192, T255, G270, C372, T468, and T489) other particular
amino acids were observed in the 512-bp
rpoB fragments of strains
SG266 and SG271, respectively.
View this table:
[in this window]
[in a new window]
|
TABLE 4. Nucleotide variations within the 512-bp fragment of the rpoB gene of K. oxytoca belonging to the oxy-1 and oxy-2 genetic groups and of strains SG271 and SG266
|
Concerning the sequence of the 387-bp 16S rDNA fragments of
strains SG266 and SG271, we observed (Table
5) different nucleotide
possibilities on the chromatograph, exactly at the nucleotide
positions that allowed us to distinguish (signature sequences)
the two 16S rDNA consensus sequences characteristic of the two
K. oxytoca genetic groups (
14). After we cloned the 387-bp fragment,
which was amplified from strains SG266 and SG271, we analyzed
the sequence of the 387-bp fragment from five clones derived
from strain SG266 and four clones derived from strain SG271.
The five clones derived from strain SG266 displayed an identical
signature sequence corresponding to that previously defined
for the
K. oxytoca genetic group oxy-1 (Table
5), whereas the
four clones derived from strain SG271 displayed three different
signature sequences that were, moreover, different from those
previously defined for the two genetic groups of
K. oxytoca (Table
5). Pairwise analysis of the sequences of the 16S rDNA
fragment of the three different clones obtained from strain
SG271 and the16S rDNA consensus sequence of each genetic group
showed (Table
5) that clone C had a high percentage of identity
with the 16S rDNA consensus sequence of the genetic group oxy-1,
whereas clone D displayed a similarly high percentage of identity
with the 16S rDNA consensus sequence of the genetic group oxy-2.
Clones A and B, which showed the same 16S rDNA signature sequence,
displayed a lower identity percentages with each 16S rDNA consensus
sequence, a percentage that was similar to that observed between
the two 16S rDNA consensus sequences (Table
5).
View this table:
[in this window]
[in a new window]
|
TABLE 5. 16S rDNA signature sequences and percentages of the 16S rDNA fragment homology between K. oxytoca genetic groups, strains SG266 and SG271, and their 16S rDNA clones
|
Extensive biochemical analysis of strains SG266 and SG271.
Although all of the genetic analyses performed indicated that
strains SG266 and SG271 belong to the
K. oxytoca taxon, we decided
to submit them to an extensive biochemical analysis since they
displayed particular features regarding the genes studied.
Although strain SG266 displayed negative tests for three biochemical reactions normally positive for K. oxytoca strains (meso-tartrate, trans-aconitate, and DL-glycerate), it was confirmed as belonging to the K. oxytoca taxon. Strain SG271, which displayed numerous negative reactions (notably for meso-tartrate, D-malate, trans-aconitate, tricarballylate, putrescine, succinate, fumarate, DL-glycerate, D-glucosamine, and L-aspartate), could only be identified as Klebsiella but without species definition.

DISCUSSION
We have previously determined that the
K. oxytoca taxon is divided
into two genetic groups (oxy-1 or oxy-2) recognizable by four
independent molecular markers (
14) and have proved that the
genetic group classification made on the basis of the analysis
of one of these four markers was confirmed by the secondary
analysis of another marker. Thus, we have classified
K. oxytoca strain ATCC 13182
T into the oxy-2 genetic group on the basis
of its 16S rDNA and
rpoB sequences available in GenBank and
then confirmed this classification by sequencing its
blaOXY gene (
14). We have also classified 15 clinical isolates identified
as
K. oxytoca through routine biochemical analysis into either
of the two genetic groups on the basis of their ERIC-1R profile
and then confirmed this classification by sequencing their
blaOXY genes (
13). However, we were unable to classify strains SG266
and SG271 into the two
K. oxytoca genetic groups on the basis
of their ERIC-1R profiles and the sequences of their
blaOXY genes (
13). Subsequently, the present study was carried out
to determine whether these two strains could be representative
of two new
K. oxytoca genetic groups.
Taking into consideration the fact that the blaOXY gene of strain SG271 displayed a lower identity percentage with the blaOXY-1 gene group (85.5% ± 0.2%) and with the blaOXY-2 gene group (84.4% ± 0.4%) than that observed between these two blaOXY gene groups (86.8% ± 0.4%), we can reasonably conclude that the blaOXY gene of strain SG271 is representative of a new blaOXY gene group that we therefore suggest naming blaOXY-3. This lower gene identity percentage resulted in the creation of a new branch of the KOXY ß-lactamase phylogenetic tree, to which only the chromosomal ß-lactamase of strain SG271 was attached. Thus, the OXY-3 ß-lactamase of strain SG271 further enhances the aspect of the phylogenetic tree of KOXY ß-lactamases. Regarding the sequence of the 512-bp fragment of the rpoB gene of strain SG271, we found six positions for which there were nucleotides specific for strain SG271 allowing us to distinguish this strain from the two genetic groups previously described (13). The third marker previously defined as being characteristic of the K. oxytoca genetic groups, namely, the 16S rDNA signature sequence, displayed new genetic features in strain SG271. In fact, by cloning the 387-bp 16S rDNA fragment from strain SG271, we were able to find three different signature sequences out of the four sequenced clones. This finding suggests the presence of at least three 16S rRNA operons in K. oxytoca and confirmed the existence of variations within the 16S rRNA operons of a same strain, as previously described for a very few bacterial species (6, 21, 26). Moreover, we found that the three different signature sequences also differed from either of the two 16S rDNA signature sequences characteristic of the two K. oxytoca genetic groups. All of these findings, combined with the fact that the ERIC-1R profile of strain SG271 did not display the oxy-1 or oxy-2 genetic group-specific bands (13), led us to conclude that we have discovered in strain SG271 a strain representative of a third genetic group in the K. oxytoca taxon. We suggest that this third genetic group be called oxy-3. The last point that we can emphasize about strain SG271 is the fact that the biochemical analysis performed by using 100 molecules as carbon source was able to identify it at only the genus level, Klebsiella, whereas all of the molecular studies that we carried out allowed for a species identification.
With regard to ß-lactam susceptibility, strain SG271 displayed a ß-lactam resistance pattern identical to that displayed by K. oxytoca strains normally producing ß-lactamase. This was also the case of strain SG266, which was confirmed to be K. oxytoca via extensive biochemical analysis. However, the results obtained for this strain with regard to the four molecular markers characteristic of the K. oxytoca genetic groups did not allow us to classify it. Indeed, even if its blaOXY gene displayed a high identity percentage with the genes of the blaOXY-1 group (95.0% ± 0.4%) and a low percentage with the genes of the blaOXY-2 group (86.2% ± 0.3%), this did not allow us to classify the SG266 strain's blaOXY gene in the blaOXY-1 group, since we had previously shown that the identity percentage within a blaOXY group was >99% (14). We therefore suggest that this gene be called blaOXY-4. Cloning experiments of the 387-bp 16S rDNA fragment of strain SG266 resulted in five clones displaying identical signature sequences that perfectly matched those of the strains belonging to the oxy-1 genetic group. Among the clones tested, we did not find any that were responsible for the variations observed in the sequence of the fragment amplified and directly sequenced from strain SG266. This result suggests that the sequences found in the five clones are probably dominant among the 16S rRNA operons of strain SG266. The two remaining oxy genetic group markers studied for strain SG266, ERIC-1R profile and singular nucleotides in the 512-bp fragment of the rpoB gene, not only confirmed that it was not possible to classify strain SG266 into the oxy-1 genetic group but also suggested that strain SG266 could belong to a subgenetic group. Indeed, on the basis of these two molecular markers, strain SG266 can clearly be distinguished from those belonging to either of the three oxy genetic groups that have been defined in the K. oxytoca taxon up to now. Finally, the possibility that strain SG266 might belong to a subgenetic group was also suggested by the position of its ß-lactamase in the ß-lactamase phylogenetic tree.
Interestingly, by discovering the two strains SG266 and SG271, we observed that the number of singular nucleotides, by which the two rpoB consensus sequences could have been differentiated (14), decreased. In fact, instead of the 17 nucleotides found to be specific for the recognition of the two genetic groups oxy-1 and oxy-2, only 6 remained specific for the oxy-1 genetic group and only 4 remained specific for the oxy-2 genetic group. However, six and nine became specific for strains SG266 and SG271, respectively. Such a discriminatory power cannot be attributed to the 16S rDNA signature sequence since the 16S rDNA fragment studied did not allow for the differentiation of strain SG266 from those of the oxy-1 genetic group.
Overall, the present study confirms that the ERIC-1R PCR method is a powerful tool to detect particular strains in the K. oxytoca taxon (13) and that the chromosomal bla gene of K. oxytoca, although it is not classified within the housekeeping gene family, is able, like housekeeping genes, to trace the bacterial diversification and evolution in the K. oxytoca taxon (14).

ACKNOWLEDGMENTS
This study was supported by a grant from the French ß-lactamase
network (Ministère de la Recherche, Paris, France).
We thank Nadine Honoré for help with methodology choices.

FOOTNOTES
* Corresponding author. Mailing address: Service de Microbiologie-Hygiène, Hôpital A. Paré, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. Phone: 33-1-49-09-55-40. Fax: 33-1-49-09-59-21. E-mail:
marie-helene.nicolas-chanoine{at}apr.ap-hop-paris.fr.


REFERENCES
1 - Anonymous. 2003. Comité de l'antibiogramme de la Societé Française de Microbiologie report 2003. Int. J. Antimicrob. Agents. 21:364-391.[CrossRef][Medline]
2 - Arakawa, Y., M. Ohta, N. Kido, M. Mori, H. Ito, T. Komatsu, Y. Fujii, and N. Kato. 1989. Chromosomal beta-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum beta-lactam antibiotics. Antimicrob. Agents Chemother. 33:63-70.[Abstract/Free Full Text]
3 - Brisse, S., and J. Verhoef. 2001. Phylogenetic diversity of Klebsiella pneumoniae and Klebsiella oxytoca clinical isolates revealed by randomly amplified polymorphic DNA, gyrA and parC genes sequencing, and automated ribotyping. Int. J. Syst. Evol. Microbiol. 51:914-925.
4 - Brodsky, L. I., A. V. Vasiliev, Y. L. Kalaidzidis, Y. S. Osipov, R. L. Tatuzov, and S. I. Feranchuk. 1992. GeneBee: the program package for biopolymer structure analysis. Dimacs 8:127-139.
5 - Brosius, J., M. L. Palmer, P. J. Kennedy, and H. F. Noller. 1978. Complete nucleotide sequence of 16S ribosomal RNA gene from Escherichia coli. Proc. Natl. Acad. Sci. USA 75:4801-4805.[Abstract/Free Full Text]
6 - Cilia, V., B. Lafay, and R. Christen. 1996. Sequence heterogeneities among 16S ribosomal RNA sequences, and their effect on phylogenetic analyses at the species level. Mol. Biol. E. 13:451-461.
7 - Drancourt, M., C. Bollet, A. Carta, and P. Rousselier. 2001. Phylogenetic analyses of Klebsiella species delineate Klebsiella and Raoultella gen. nov., with description of Raoultella ornithinolytica comb. nov., Raoultella terrigena comb. nov., and Raoultella planticola comb. nov. Int. J. Syst. Evol. Microbiol. 51:925-932.[Abstract]
8 - Farzaneh, S., J. Peduzzi, L. Sofer, A. Reynaud, M. Barthelemy, and R. Labia. 1997. Characterization and amino acid sequence of the OXY-2 group for beta-lactamase of pI 5.7 isolated from aztreonam-resistant Klebsiella oxytoca strain HB60. J. Antimicrob. Chemother. 40:789-795.[Abstract/Free Full Text]
9 - Fournier, B., C. Y. Lu, P. H. Lagrange, R. Krishnamoorthy, and A. Philippon. 1995. Point mutation in the Pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytoca. Antimicrob. Agents Chemother. 36:1365-1368.
10 - Fournier, B., and P. H. Roy. 1997. Variability of chromosomally encoded beta-lactamases from Klebsiella oxytoca. Antimicrob. Agents Chemother. 41:1641-1648.[Abstract]
11 - Fournier, B., P. H. Roy, P. H. Lagrange, and A. Philippon. 1996. Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2. Antimicrob. Agents Chemother. 40:454-459.[Abstract]
12 - Granier, S. A., K. Bush, V. Leflon-Guibout, F. W. Goldstein, and M. H. Nicolas-Chanoine. 2002. The extended-spectrum K1 beta-lactamase from Klebsiella oxytoca SC 10,436 is a member of the blaOXY-2 family of chromosomal Klebsiella enzymes. Antimicrob. Agents Chemother. 46:2056-2057.[Free Full Text]
13 - Granier, S. A., V. Leflon-Guibout, F. W. Goldstein, and M. H. Nicolas-Chanoine. 2003. Enterobacterial repetitive intergenic consensus 1R PCR Assay for detection of Raoultella sp. isolates among strains identified as K. oxytoca in clinical laboratory. J. Clin. Microbiol. 41:1740-1742.[Abstract/Free Full Text]
14 - Granier, S. A., L. Plaisance, V. Leflon-Guibout, E. Lagier, S. Morand, F. W. Goldstein, and M. H. Nicolas-Chanoine. 2003. Recognition of two genetic groups in Klebsiella oxytoca taxon on the basis of the chromosomal beta-lactamase and housekeeping gene sequences as well as ERIC PCR typing. Int. J. Syst. Evol. Microbiol. 53:661-668.[Abstract/Free Full Text]
15 - Jain, K., K. Radsak, and W. Mannheim. 1974. Differentiation of the oxytocum group from Klebsiella by deoxyribonucleic acid-deoxyribonucleic acid hybridization. Int. J. Syst. Bacteriol. 24:402-407.[Abstract/Free Full Text]
16 - Kimura, K., Y. Arakawa, S. Ohsuka, H. Ito, K. Suzuki, H. Kurokawa, N. Kato, and M. Ohta. 1996. Molecular aspects of high-level resistance to sulbactam-cefoperazone in Klebsiella oxytoca clinical isolates. Antimicrob. Agents Chemother. 40:1988-1994.[Abstract]
17 - Mariotte, S., P. Nordmann, and M. H. Nicolas. 1994. Extended-spectrum beta-lactamase in Proteus mirabilis. J. Antimicrob. Chemother. 33:925-935.[Abstract/Free Full Text]
18 - Mollet, C., M. Drancourt, and D. Raoult. 1997. rpoB sequence analysis as a novel basis for bacterial identification. Mol. Microbiol. 26:1005-1011.[CrossRef][Medline]
19 - Morgenstern, B. 1999. Dialign 2: improvement of the segment-to-segment approach to multiple sequence alignment. Bioinformatics 15:203-210.[Abstract/Free Full Text]
20 - Myers, E. W., and W. Miller. 1988. Optimal alignments in linear space. Comput. Appl. Biosci. 4:11-17.[Abstract/Free Full Text]
21 - Reischl, U., K. Feldmann, L. Naumann, B. J. Gaugler, B. Ninet, and B. Hirschel. 1998. 16S rRNA sequence diversity in Mycobacterium celatum strains caused by the presence of two different copies of 16S rRNA gene. J. Clin. Microbiol. 36:1761-1764.[Abstract/Free Full Text]
22 - Sirot, D., R. Labia, P. Pouedras, C. Chanal-Claris, C. Cerceau, and J. Sirot. 1998. Inhibitor-resistant OXY-2 derived beta-lactamase produced by Klebsiella oxytoca. Antimicrob. Agents Chemother. 42:2184-2187.[Abstract/Free Full Text]
23 - Sirot, J., M. H. Nicolas-Chanoine, H. Chardon, J. L. Avril, C. Cattoen, J. C. Croix, H. Dabernat, T. Fosse, J. C. Ghnassia, E. Lecaillon, A. Marmonier, M. Roussel-Delvallez, C. J. Soussy, A. Trevoux, F. Vandenesh, C. Dib, N. Moniot-Ville, and Y. Rezvani. 2002. Susceptibility of Enterobacteriaceae to beta-lactam agents and fluoroquinolones: a 3-year survey in France. Clin. Microbiol. Infect. 8:207-213.[CrossRef][Medline]
24 - Sykes, R. B., D. P. Bonner, K. Bush, and N. H. Georgopapadakou. 1982. Aztreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria. Antimicrob. Agents Chemother. 21:85-92.[Abstract/Free Full Text]
25 - Wu, S. W., K. Dornbusch, and G. Kronvall. 1999. Genetic characterization of resistance to extend-spectrum beta-lactams in Klebsiella oxytoca isolates recovered from patients with septicemia at hospitals in the Stockholm area. Antimicrob. Agents Chemother. 43:1294-1297.[Abstract/Free Full Text]
26 - Yap, W. H., Z. Zhang, and Y. Wang. 1999. Distinct types of rRNA operons exist in the genome of the actinomycete Thermomonospora chromogena and evidence for horizontal transfer of an entire rRNA operon. J. Bacteriol. 181:5201-5209.[Abstract/Free Full Text]
Antimicrobial Agents and Chemotherapy, September 2003, p. 2922-2928, Vol. 47, No. 9
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.9.2922-2928.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Fevre, C., Jbel, M., Passet, V., Weill, F.-X., Grimont, P. A. D., Brisse, S.
(2005). Six Groups of the OXY {beta}-Lactamase Evolved over Millions of Years in Klebsiella oxytoca. Antimicrob. Agents Chemother.
49: 3453-3462
[Abstract]
[Full Text]
-
Decre, D., Burghoffer, B., Gautier, V., Petit, J.-C., Arlet, G.
(2004). Outbreak of multi-resistant Klebsiella oxytoca involving strains with extended-spectrum {beta}-lactamases and strains with extended-spectrum activity of the chromosomal {beta}-lactamase. J Antimicrob Chemother
54: 881-888
[Abstract]
[Full Text]
-
Haeggman, S., Lofdahl, S., Paauw, A., Verhoef, J., Brisse, S.
(2004). Diversity and Evolution of the Class A Chromosomal Beta-Lactamase Gene in Klebsiella pneumoniae. Antimicrob. Agents Chemother.
48: 2400-2408
[Abstract]
[Full Text]